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Why are the next steps in biomaterials
research so difficult?
Strategically, ‘biomaterials research’ should be refocus-
ing its science on new areas – but it has not!
Traditionally, biomaterials research has been heavily
leveraged in ‘synthetic biomaterials product-testing’,
but it should be moving towards ‘biological materials
and clinical research’. There is an adage (Lubin’s Rule)
that says ‘If another scientist thought your research was
more important than his, he would drop what he is
doing and do what you are doing’ (1). This appropri-
ately describes the struggle of biomaterials’ research
investigators to try to move into the next age for
biomaterials research. There are several historical
impediments here, so let’s start at the beginning.
Biomaterials research should encompass three major
focuses: (i) complete characterization of the structure-
property events within restorative materials (synthetic
or biological), (ii) the biological interactions at their
interfaces with biological tissues, and (iii) the changing
events of the underlying biological tissues. This inter-
play (materials, interfaces, tissues) has been the unre-
alized research goal for biomaterials’ scientists for many
years. To date, the overwhelming focus has been on
laboratory characterization material properties. John
Keller (pers. comm., Northwestern University, Chicago,
IL, USA) once opined that the ‘bio’ seemed to be
missing from ‘biomaterials’.
Two important transitions now are underway that
begin to address the problems. Firstly, there is
increasing pressure to understand interfaces and
tissues as part of expanding focus on clinical research
for biomaterials. Secondly, there is strong pressure for
biomaterials scientists to embrace tissue engineering
and move towards the development and testing of
true ‘biological materials’ (2). Both of these transi-
tions are part of the upcoming Journal of Oral
Rehabilitation 2006 Summer School Workshop (theme:
oral biomaterials – from material science to biology –
the clinical consequences) on September 20–24 in
Bevagna, Italy. Let’s consider each of these major
transitions more carefully.
Concern for the need for clinical research in bioma-
terials actually was first emphasized in the mid-1960 s
by Ryge (3). While it has been popular in the last decade
to call for evidence-based dentistry, the actual push
began long ago. In the absence of financial incentives,
clinical research has been severely hindered for many
years. Despite this problem, Ryge led the effort to put
into place a system for collecting information about the
clinical performance of restorative materials (USPHS
guidelines) that was based on ‘direct’ patient observa-
tions (4). Realizing the possible value of extending
direct evaluation methods, Leinfelder (5) and others (6)
embarked on using impression techniques to capture
intra-oral morphologic data and create working casts for
subsequent laboratory analysis of events. This ‘indirect’
approach has been the primary method for quantitative
measurement monitoring of changes such as occlusal
wear (7) over the last 25 years. Direct and indirect
clinical research methods for restorative materials have
only been able to evolve because of the funding support
of dental materials manufacturers. Even then, their
funding has been very limited in numbers and
amounts. The National Institute for Dental and Cranio-
facial Research (NIDCR), until recently, has shown no
interest in supporting clinical research of restorative
materials. Since 2002, NIH (8) has declared a strong
interest in conducting translational research and in-
cludes clinical research under that umbrella. However,
that movement so far has been to increase clinical data
collection and not to enhance clinical research tech-
niques. Thus, clinical research involving biomaterials
continues to be stalled for the short term.
For most of the history of dental biomaterials
research, the focus has been on the development and
testing of ‘synthetic biomaterials’. However, since the
mid-1990 s, there has been increasing interest and
emphasis (particularly by NIH) in developing and testing
‘biological biomaterials’ that are associated with tissue
engineering. While older biomaterials’ scientists may
not have much depth in biological science, the materi-
als’ science training of these same individuals would
seem to position them well to apply those principles in
arenas such as tissue engineering. Still, the migration of
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materials’ scientists into this area has been arguably
slow, at best. The continuing reduction in the number of
funded biomaterials’ scientists is stark evidence of this
trend and unfortunate circumstance. Biomaterials’ sci-
entists have fought to a losing battle with NIH to
preserve a traditional non-biological focus instead.
Journals and journal editors have watched from the
sidelines for several years as these events unfolded. They
had hoped for a rapid shift towards clinical research.
Journals desire relevant clinical information. The Journal
of Oral Rehabilitation, under Peter Svensson’s leadership,
has clearly refocused its priorities to exclude routine
materials testing reports. Readers have demanded more
useful information about long-term clinical performance
of restorative materials for their own guidance in
selection and manipulation. This tug-of-war between
authors and readers has not waned. Research reports
continue to be strongly dominated by laboratory testing
of commercial products. A preliminary examination of
product testing levels (9) reported that during the 5- to -
15 year product lives of popular dental materials prod-
ucts in such categories as bonding systems, composites,
or cements, there has been a remarkable output of ‘278
research articles per product’ generated within the
biomedical literature. Materials have been tested and
retested. None of these articles focused on complete
characterization. Rather, no more than a couple at a time
of the forty or more possible physical, chemical, mechan-
ical, or biological properties was ever reported.
The quantity of published biomaterials information
continues to escalate. It is not driven by new scientific
thrusts. All of the evidence indicates that increasing
publication is driven by more of the same old thing,
laboratory product testing. Typically, more than 700
publications associated with traditional biomaterials
topics appear in the biomedical literature each year
(10). An earlier trend analysis (11), pointed out that
>85% of these articles involved laboratory research
results. One might wonder why this should happen if
there was such a strong concern about the usefulness of
laboratory testing results. Three things seem to dictate
against any major change. Firstly, there is very little real
clinical research to replace laboratory information.
Secondly, new journals are being created every day,
need content, and are willing to accept extensive
numbers of laboratory studies in the early phases of
their operation. A huge number of articles are now
published in the scientific literature every day. Third,
marketing and sales operations, in the absence of longer
term clinical data, thrive on laboratory results as
evidence for their new products, and continue to
actively provide that research support. Thus, there is
no true pressure against continued restorative materials
product-testing as a way of life for biomaterials research.
Perhaps another unfortunate consequence of these
events is bad timing. The cohort of biomaterials scien-
tists is dominated by individuals in the twilight stages of
their careers. They have no interest in being ‘reinvent-
ed’ or ‘shifting their focus’. At this moment, the mean
age of International Association for Dental Research
(IADR) scientists (including biomaterials scientists) is
60.5 years old. More than 50% of the current bioma-
terial’s scientists could be retired within 5–8 years. Of
the remaining group, one might argue only the young-
est portion (perhaps 10–15%) has been trained in the
new science. Another portion (25–30%) may still be
waiting for career opportunities to refocus their efforts
into biological biomaterials. A further portion (10%)
could be in no-man’s land, looking at considering
options to abandon their scientific participation in the
field entirely for administration and/or teaching. All of
this means that far fewer future scientists will be
available to conduct the new science of biological
biomaterials and even fewer may carry the torch for
clinical research for biomaterials.
Where do we go from here? New scientists will shift
from synthetic towards biological materials testing.
A limited number of new scientists will continue to
develop the sophistication of clinical research methods.
Research investigations will gradually shift towards
understanding the complex intra-oral environment and
the shifting interactions of materials, interfaces, and
tissues over time. Editors will press for this change by
refusing to support the publication of product-testing
experiments. If all of these were accompanied by strong
research funding, then this new world of research
would be fast upon us. However, limited research
resources and the loss of many senior investigators will
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